BrainStorm Receives Notice of Allowance to Grant European Patent Covering its … – 4-traders (press release)
| 4-traders (press release) BrainStorm Cell Therapeutics (OTC.QB: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, today announced that it has received notification from the European Patent Office (EPO) of its intention to grant the … Stem Cells Improved Condition of Patient with Cognitive DisorderInformation-Analytic Agency NEWS.am |
